首页 > 市场调查报告书 > 製药

疫苗

市场调查报告书

商品编码

1705671

疫苗市场按类型、技术、适应症、给药途径及地区划分

Vaccines Market, By Type, By Technology, By Disease Indication, By Route of Administration, By Geography

出版日期: 2025年02月19日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计 2025 年全球疫苗市场规模为 819.1 亿美元，到 2032 年将达到 1,248.8 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 6.2%。

报告范围		报告详细信息
基准年	2024	2025年的市场规模	819.1亿美元
效能数据	2020-2024	预测期	2025-2032
预测期：2025-2032年复合年增长率：	6.20%	2032年价值预测	1248.8亿美元

数字。 2025年各地区疫苗市场占有率（%）

由于各种感染疾病的流行程度不断提高以及疫苗生产技术的进步，全球疫苗市场在过去几年中一直稳步增长。疫苗有助于增强对某些疾病的免疫力，并保护高风险族群免受危险感染疾病的致命影响。人们对疫苗接种的认识不断提高，尤其是在开发中国家，这推动了全球对先进且价格合理的疫苗的需求。此外，各大厂商推出的联合疫苗也促进了疫苗接种覆盖率的提高，减轻了医疗资源的压力。预计预测期内各国政府和国际组织对疫苗接种计画的持续支持将推动全球疫苗市场的成长。

市场动态：

全球疫苗市场主要受到感染疾病率上升、疫苗製造技术进步以及政府对疫苗接种计划日益重视的推动。根据世界卫生组织 (WHO) 统计，疫苗接种每年可防止约 200 万至 300 万人死亡。此外，针对某些疾病的强制疫苗接种和全球消灭疾病的努力也为市场成长提供了动力。然而，新疫苗研发成本高、监管核准程序严格、以及因错误讯息而犹豫接种疫苗等因素阻碍了疫苗的广泛应用。同时，无需冷藏即可承受高温的耐热疫苗、可提供针对变异病毒保护的细胞疫苗技术以及增加中低收入国家疫苗接种率的倡议的开发预计将在未来几年为企业带来丰厚的机会。

本研究的主要特点

本报告对全球疫苗市场进行了详细分析，并给出了预测期（2025-2032 年）的市场规模（以十亿美元为单位）和年复合成长率（CAGR%），假设 2024 年为基准年。

它还强调了各个领域的潜在商机，并说明了该市场的有吸引力的投资提案矩阵。

它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。

本报告根据公司亮点、产品系列、主要成就、财务表现和策略等参数，提供了全球疫苗市场主要企业的概况。

研究涉及的主要企业包括辉瑞、默克、赛诺菲巴斯德、GlaxoSmithKline Plc(GSK)、Astra Zeneca、强生、CSL 有限公司和印度血清研究所。

本报告提供的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。

全球疫苗市场报告针对该行业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和金融分析师。

透过分析全球疫苗市场所使用的各种策略矩阵，相关人员将更容易做出决策。

北美洲
美国
加拿大
拉丁美洲
巴西
阿根廷
墨西哥
其他拉丁美洲
欧洲
德国
英国
西班牙
法国
义大利
俄罗斯
其他欧洲国家
亚太地区
中国
印度
日本
澳洲
韩国
ASEAN
其他亚太地区
中东
海湾合作委员会国家
以色列
其他中东地区
非洲
南非
北非
中部非洲

第十章竞争格局

GlaxoSmithKline plc（GSK）
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm（China National Pharmaceutical Group）
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc

第 11 章分析师建议

命运之轮
分析师观点
一致的机会图

第十二章参考文献与调查方法

参考
调查方法
关于出版商

简介目录

Product Code: CMI4914

Global Vaccines Market is estimated to be valued at USD 81.91 Bn in 2025 and is expected to reach USD 124.88 Bn by 2032, growing at a compound annual growth rate (CAGR) of 6.2% from 2025 to 2032.

Report Coverage		Report Details
Base Year:	2024	Market Size in 2025:	USD 81.91 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	6.20%	2032 Value Projection:	USD 124.88 Bn

Figure. Vaccines Market Share (%), By Region 2025

The global vaccines market has been witnessing steady growth over the past few years due to the rising prevalence of various infectious diseases and technological advancements in vaccine production. Vaccines aid in building immunity against specific diseases and allow populations at risk to be protected from the life-threatening effects of dangerous infections. Growing awareness about immunization, especially in developing nations is propelling the demand for advanced and affordable vaccines globally. Furthermore, the introduction of combination vaccines by major manufacturers is encouraging higher vaccination rates and reducing the burden on healthcare resources. Continued support from governments and international organizations towards immunization programs is expected to drive the global vaccines market growth during the forecast period.

Market Dynamics:

The global vaccines market is primarily driven by the rising incidence of infectious diseases, technological advancements in vaccine production, and growing focus on immunization programs by governments. According to the World Health Organization (WHO), immunization averts an estimated 2-3 million deaths annually. Mandates on vaccination of certain diseases and worldwide efforts towards disease eradication also provide momentum to market growth. However, high R&D costs associated with new vaccine development, stringent regulatory approvals, and vaccine hesitancy due to misinformation are some of the factors hindering the widespread adoption of vaccines. On the other hand, development of thermostable vaccines that can withstand high temperatures without refrigeration, cell-based vaccine technologies offering protection against mutating viruses, and initiatives to drive vaccine uptake in low and middle-income countries are expected to unlock lucrative opportunities for players in the coming years.

Key features of the study:

This report provides in-depth analysis of the global vaccines market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Pfizer, Merck, Sanofi Pasteur, GlaxoSmithKline (GSK), AstraZeneca, Johnson & Johnson, CSL Limited, and Serum Institute of India

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vaccines market.

Detailed Segmentation-

By Type Insights (Revenue, USD Bn, 2020 - 2032)
- Monovalent Vaccines
- Mulitvalent Vaccines
By Technology Insights (Revenue, USD Bn, 2020 - 2032)
- Conjugate Vaccines
- Recombinant Vaccines
- Inactivated and Subunit Vaccines
- Live Attenuated Vaccines
- Toxoid Vaccines
- Other Vaccine Technologies
By Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
- Tablets/Capsules
- Liquids
- Creams
- Gels
- Others
By Disease Indication Insights (Revenue, USD Bn, 2020 - 2032)
- Pneumococcal Disease
- Influenza
- Combination Vaccines
- HPV
- Meningococcal Disease
- Herpes Zoster
- Rotavirus
- MMR
- Varicella
- Hepatitis
- DTP
- Polio
- RSV
- Other Disease Indications
By Route Of Administration: Insights (Revenue, USD Bn, 2020 - 2032)
- Intramuscular
- Subcutaneous
- Oral
- Intranasal
By Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- GlaxoSmithKline plc (GSK)
- Merck & Co., Inc.
- Pfizer Inc.
- Sanofi
- Moderna, Inc.
- AstraZeneca
- Johnson & Johnson
- Novavax, Inc.
- CSL Limited
- Emergent BioSolutions Inc.
- Bharat Biotech
- Serum Institute of India
- BioNTech SE
- Takeda Pharmaceutical Company
- Sinovac Biotech Ltd.
- Sinopharm (China National Pharmaceutical Group)
- Vaxart, Inc.
- Inovio Pharmaceuticals, Inc.
- Valneva SE
- Vaccitech plc

1. RESEARCH OBJECTIVES AND ASSUMPTIONS

Research Objectives
Assumptions
Abbreviations

2. MARKET PURVIEW

Report Description
- Market Definition and Scope
Executive Summary
- Global Vaccines Market, By Type
- Global Vaccines Market, By Technology
- Global Vaccines Market, By Dosage Form
- Global Vaccines Market, By Disease Indication
- Global Vaccines Market, By Route of Administration
- Global Vaccines Market, By Region

3. MARKET DYNAMICS, REGULATIONS, AND TRENDS ANALYSIS

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Global Vaccines Market, By Type, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Monovalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Multivalent Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Vaccines Market, By Technology, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Conjugate Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Recombinant Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Inactivated and Subunit Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Live Attenuated Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Toxoid Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Vaccine Technologies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Vaccines Market, By Dosage Form, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Tablets/Capsules
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Liquids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Creams
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Gels
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Vaccines Market, By Disease Indication, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Pneumococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Influenza
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Combination Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
HPV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Meningococcal Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Herpes Zoster
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Rotavirus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
MMR
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Varicella
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Hepatitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
DTP
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Polio
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
RSV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Other Disease Indications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Vaccines Market, By Route of Administration, 2025-2032, (USD Bn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
Intramuscular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Vaccines Market, By Region, 2020 - 2032, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2020 - 2032, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Disease Indication, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa

10. COMPETITIVE LANDSCAPE

GlaxoSmithKline plc (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Merck & Co., Inc.
Pfizer Inc.
Sanofi
Moderna, Inc.
AstraZeneca
Johnson & Johnson
Novavax, Inc.
CSL Limited
Emergent BioSolutions Inc.
Bharat Biotech
Serum Institute of India
BioNTech SE
Takeda Pharmaceutical Company
Sinovac Biotech Ltd.
Sinopharm (China National Pharmaceutical Group)
Vaxart, Inc.
Inovio Pharmaceuticals, Inc.
Valneva SE
Vaccitech plc

11. Analyst Recommendations

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us

02-2729-4219

+886-2-2729-4219

License/价格

疫苗市场按类型、技术、适应症、给药途径及地区划分